BOSTON SCIENTIFIC CORP

NYSE: BSX (Boston Scientific Corporation)

Last update: 6 days ago, 1:49PM

96.71

4.72 (5.13%)

  • 1D 5.13%
  • 5D 5.94%
  • 1M 6.91%
  • 6M 23.96%
  • YTD 8.20%
  • 1Y 60.51%
  • 5Y 127.18%
Previous Close 91.99
Open 96.68
Volume 7,523,884
Avg. Volume (3M) 5,688,127
Market Cap 142,534,098,944
Price / Earnings (TTM) 79.93
Price / Earnings (Forward) 33.90
Price / Sales 8.84
Price / Book 6.75
52 Weeks Range
59.08 (-38%) — 97.13 (0%)
Earnings Date 5 Feb 2025
Profit Margin 11.26%
Operating Margin (TTM) 17.06%
Diluted EPS (TTM) 1.21
Quarterly Revenue Growth (YOY) 19.30%
Quarterly Earnings Growth (YOY) -7.10%
Total Debt/Equity (MRQ) 53.72%
Current Ratio (MRQ) 1.48
Operating Cash Flow (TTM) 2.94 B
Levered Free Cash Flow (TTM) 1.80 B
Return on Assets (TTM) 4.90%
Return on Equity (TTM) 8.92%

Market Trend

Short Term Medium Term
Industry Medical Devices (US) Mixed Mixed
Medical Devices (Global) Mixed Mixed
Stock Boston Scientific Corporation Bullish Bullish

AIStockmoo Score

-0.5
Analyst Consensus 1.5
Insider Activity -5.0
Price Volatility -3.0
Technical Moving Averages 0.0
Technical Oscillators 4.0
Average -0.50

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
BSX 143 B - 79.93 6.75
SYK 139 B 0.89% 39.08 6.83
PHG 23 B - - 1.86
ABT 204 B 1.93% 35.47 5.04
MDT 102 B 3.49% 24.43 2.25
GMED 11 B - 135.39 2.91

Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
Sector Healthcare
Industry Medical Devices
Investment Style Large Core
% Held by Insiders 0.17%
% Held by Institutions 92.43%

Ownership

Name Date Shares Held
Bollard Group Llc 30 Sep 2024 21,243,551
52 Weeks Range
59.08 (-38%) — 97.13 (0%)
Price Target Range
86.00 (-11%) — 110.00 (13%)
High 110.00 (JP Morgan, 13.74%) Buy
110.00 (Truist Securities, 13.74%) Buy
110.00 (TD Cowen, 13.74%) Buy
110.00 (Mizuho, 13.74%) Buy
Median 100.00 (3.40%)
Low 86.00 (Needham, -11.07%) Hold
Average 102.46 (5.95%)
Total 12 Buy, 1 Hold
Avg. Price @ Call 87.95
Firm Date Target Price Call Price @ Call
Truist Securities 18 Dec 2024 110.00 (13.74%) Buy 88.03
JP Morgan 16 Dec 2024 110.00 (13.74%) Buy 90.46
TD Cowen 12 Dec 2024 110.00 (13.74%) Buy 90.42
21 Oct 2024 100.00 (3.40%) Buy 88.05
Citigroup 11 Dec 2024 107.00 (10.64%) Buy 90.56
24 Oct 2024 98.00 (1.33%) Buy 85.10
Wells Fargo 11 Dec 2024 100.00 (3.40%) Buy 90.56
24 Oct 2024 98.00 (1.33%) Buy 85.10
Canaccord Genuity 09 Dec 2024 101.00 (4.44%) Buy 88.72
24 Oct 2024 98.00 (1.33%) Buy 85.10
Bernstein 24 Oct 2024 100.00 (3.40%) Buy 85.10
Mizuho 24 Oct 2024 110.00 (13.74%) Buy 85.10
Morgan Stanley 24 Oct 2024 100.00 (3.40%) Buy 85.10
RBC Capital 24 Oct 2024 98.00 (1.33%) Buy 85.10
B of A Securities 22 Oct 2024 100.00 (3.40%) Buy 88.01
Needham 18 Oct 2024 86.00 (-11.07%) Hold 88.07
Stifel 18 Oct 2024 100.00 (3.40%) Buy 88.07
Show more
Name Avg. Buy ($) Avg. Sell ($) Net Quantity Net Value ($)
BRENNAN DANIEL J. - 90.01 -14,901 -1,344,231
BROWN VANCE R - 89.32 -1,991 -177,836
BUTCHER ARTHUR C - 89.32 -4,416 -394,437
FITZGERALD JOSEPH MICHAEL - 89.32 -6,425 -573,881
MAHONEY MICHAEL F - 89.32 -25,656 -2,291,594
MIRVISS JEFFREY B. - 90.01 -10,430 -941,406
SORENSON JOHN BRADLEY - 89.80 -8,588 -770,536
Aggregate Net Quantity -72,407
Aggregate Net Value ($) -6,493,921
Aggregate Avg. Buy ($) -
Aggregate Avg. Sell ($) 89.70
Name Holder Date Type Quantity Price Value ($)
MIRVISS JEFFREY B. Officer 03 Jan 2025 Automatic sell (-) 7,152 90.69 648,615
BRENNAN DANIEL J. Officer 03 Jan 2025 Automatic sell (-) 9,689 90.69 878,695
SORENSON JOHN BRADLEY Officer 03 Jan 2025 Automatic sell (-) 2,342 90.69 212,396
SORENSON JOHN BRADLEY Officer 02 Jan 2025 Automatic sell (-) 4,119 89.38 368,156
MIRVISS JEFFREY B. Officer 01 Jan 2025 Disposed (-) 3,278 89.32 292,791
MIRVISS JEFFREY B. Officer 01 Jan 2025 Option execute 10,430 - -
BRENNAN DANIEL J. Officer 01 Jan 2025 Disposed (-) 5,212 89.32 465,536
BRENNAN DANIEL J. Officer 01 Jan 2025 Option execute 14,901 - -
BUTCHER ARTHUR C Officer 01 Jan 2025 Disposed (-) 4,416 89.32 394,437
BUTCHER ARTHUR C Officer 01 Jan 2025 Option execute 8,940 - -
FITZGERALD JOSEPH MICHAEL Officer 01 Jan 2025 Disposed (-) 6,425 89.32 573,881
FITZGERALD JOSEPH MICHAEL Officer 01 Jan 2025 Option execute 13,907 - -
BROWN VANCE R Officer 01 Jan 2025 Disposed (-) 1,991 89.32 177,836
BROWN VANCE R Officer 01 Jan 2025 Option execute 6,456 - -
MAHONEY MICHAEL F Officer 01 Jan 2025 Disposed (-) 25,656 89.32 2,291,594
MAHONEY MICHAEL F Officer 01 Jan 2025 Option execute 57,121 - -
SORENSON JOHN BRADLEY Officer 01 Jan 2025 Disposed (-) 2,127 89.32 189,984
SORENSON JOHN BRADLEY Officer 01 Jan 2025 Option execute 4,469 - -
Show more

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2025 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria